Literature DB >> 19284417

Solitary plasmocytoma: improvement in critical organs sparing by means of helical tomotherapy.

Cyrus Chargari1, Youlia M Kirova, Sofia Zefkili, Lucas Caussa, Malika Amessis, Rémi Dendale, François Campana, Alain Fourquet.   

Abstract

PURPOSE: Helical tomotherapy (HT) was assessed in two patients with paramedullar solitary bone plasmocytoma. We compared doses delivered to critical organs, according HT plan or tridimensional conformal plan. METHODS AND MATERIALS: One male (patient no. 1), 67 yr-old and one female (patient no. 2), 37-yr-old, with histologically, biologically and radiological confirmed paramedullar solitary plasmocytoma have been treated in our department between November 2007 and February 2008 using HT. The prescription dose was 40 Gy in 20 fractions. This HT treatment planning was compared with a routine dosimetric work that was executed for a standard conformal radiotherapy treatment planning.
RESULTS: Treatment tolerance was excellent, without any side effects. Both patients achieved 9-month complete remission. HT resulted in substantial critical organs sparing. For patient no. 1, dose delivered to 20% of the total intestine volume was reduced from 28 Gy for conformal radiotherapy to 13 Gy for HT. Radiation dose delivered to 20% of the left kidney was reduced from 25 Gy to 7 Gy. For patient no. 2, volume of left lung that received at least 20 Gy was 12% for conformal radiotherapy vs. 6% for HT.
CONCLUSIONS: For paramedullar solitary plasmocytoma, HT has the potential to significantly improve the quality of the dose distribution both in terms of better dose homogeneity within the planning target volume and more efficient sparing of critical organs.

Entities:  

Mesh:

Year:  2009        PMID: 19284417     DOI: 10.1111/j.1600-0609.2009.01251.x

Source DB:  PubMed          Journal:  Eur J Haematol        ISSN: 0902-4441            Impact factor:   2.997


  5 in total

1.  Applications of new irradiation modalities in patients with lymphoma: Promises and uncertainties.

Authors:  Youlia M Kirova; Cyrus Chargari
Journal:  World J Radiol       Date:  2011-03-28

2.  Volumetric modulated arc radiotherapy for limited osteosclerotic myeloma.

Authors:  Aurélie Robles; Antonin Levy; Coralie Moncharmont; Lamine Farid; Jean-Baptiste Guy; Nadia Malkoun; Lysian Cartier; Cyrus Chargari; Isabelle Guichard; Jean-Noël Talabard; Guy de Laroche; Nicolas Magné
Journal:  World J Radiol       Date:  2013-04-28

3.  Helical tomotherapy and systemic targeted therapies in solitary plasmacytoma: Pilot study.

Authors:  Nadia Wiazzane; Cyrus Chargari; Corine Plancher; Jerome Tamburini; Bernard Asselain; Alain Fourquet; Didier Bouscary; Youlia M Kirova
Journal:  World J Radiol       Date:  2013-06-28

4.  Could helical tomotherapy do whole brain radiotherapy and radiosurgery?

Authors:  Youlia M Kirova; Cyrus Chargari; Sofia Zefkili; François Campana
Journal:  World J Radiol       Date:  2010-04-28

5.  Further developments for improving response and tolerance to irradiation for advanced renal cancer: concurrent (mTOR) inhibitor RAD001 and helical tomotherapy.

Authors:  Youlia M Kirova; Vincent Servois; Cyrus Chargari; Malika Amessis; Marc Zerbib; Philippe Beuzeboc
Journal:  Invest New Drugs       Date:  2010-12-14       Impact factor: 3.850

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.